Evidence map›Paper›PMID 36541778›Full record

ArticleMicrobiology spectrum2023

Identification and Characterization of Corynaridin, a Novel Linaridin from Corynebacterium lactis.

Efthimia Pashou, Sebastian J Reich, Alexander Reiter, Dominik Weixler, Bernhard J Eikmanns, Marco Oldiges, Christian U Riedel, Oliver Goldbeck

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Efthimia PashouInstitute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.
Sebastian J ReichInstitute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.
Alexander ReiterInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.
Dominik WeixlerInstitute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.
Bernhard J EikmannsInstitute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.
Marco OldigesInstitute of Bio- and Geosciences, IBG-1: Biotechnology, Forschungszentrum Jülich GmbH, Jülich, Germany.
Christian U RiedelInstitute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.ORCID 0000-0001-7134-7085
Oliver GoldbeckInstitute of Microbiology and Biotechnology, University of Ulm, Ulm, Germany.
Universität Ulm · DEForschungszentrum Jülich · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genome analysis of Corynebacterium lactis revealed a bacteriocin gene cluster encoding a putative bacteriocin of the linaridin family of ribosomally synthesized and posttranslationally modified peptides (RiPPs). The locus harbors typical linaridin modification enzymes but lacks genes for a decarboxylase and methyltransferase, which is unusual for type B linaridins. Supernatants of Corynebacterium lactis RW3-42 showed antimicrobial activity against Corynebacterium glutamicum. Deletion of the precursor gene

Indexed as

ActinobacteriaBacteriocinsAnimalsAnti-Bacterial AgentsBacteriaCorynebacteriumHumansMammalsPeptidesAnti-Bacterial AgentsBacteriocinsPeptidesantimicrobial peptidesbacteriocinsCorynebacteriumlinaridin

Identifiers

PMID36541778
PMCPMC9927463
OpenAlexW4312045993

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.